SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor ...
SANTA CLARA, Calif. & AUSTIN, Texas--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business ...
OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...
Affymetrix’ QuantiGene ViewRNA assay will be available in Q3 2012 on the Leica BOND RX platform. Affymetrix and Leica Microsystems report a worldwide collaboration that automates Affymetrix’ ...
via PRWEB - CollabRx, Inc. CLRX +6.80%, a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. AFFX +2.42%, an industry leader in ...
Technology combines ScreenCell’s isolation devices with Affymetrix’ QuantiGene ViewRNA assay. Affymetrix signed a worldwide distribution agreement for ScreenCell’s isolation devices and dilution ...
Affymetrix Inc., a pioneer in creating breakthrough tools that are driving the genomic revolution, and Leica Microsystems, a world leader in microscopes and scientific instruments, has signed a ...
(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...
Affymetrix, Inc. (Nasdaq:AFFX) today announced the launch of the Axiom Genotyping Solution, its next-generation array technology designed to match the significant rise in genetic content generated by ...
Affymetrix, Inc. (Nasdaq: AFFX) and Beckman Coulter, Inc. today announced that they have entered into an agreement to offer researchers co-developed products from the market leaders in microarrays and ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Affymetrix, a provider of scalable, innovative genomic analysis tools, and ScreenCell, a privately-held company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback